Re: Nicolas Mottet, Joaquim Bellmunt, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. European Association of Urology; 2017. http://uroweb.org/guideline/prostate-cancer-Reference-Cited by-同舟云学术

Re: Nicolas Mottet, Joaquim Bellmunt, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. European Association of Urology; 2017. http://uroweb.org/guideline/prostate-cancer

Published:2018-05 Issue:5 Volume:73 Page:e134-e135
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Morote Juan,Comas Imma,Planas Jacques

Publisher

Elsevier BV

Subject

Urology

Reference5 articles.

1. EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer;Mottet,2017

2. Measurement of serum testosterone during androgenic suppression in patients with prostate cancer: a systematic review;Morote;Acta Urol Esp,2016

3. Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement;Rosner;J Clin Endocrinol Metab,2007

4. Morote J, Comas I, Planas J, et al. Serum testosterone levels in prostate cancer patients undergoing luteinizing hormone–releasing hormone agonist treatment. Clin Genitourin Cancer. In press. doi:10.1016/j.clgc.2017.10.025.

5. Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients;Morote;J Biomed Sci,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen Deprivation Therapy in Prostate Cancer: A Practical Approach to Complex Clinical Scenarios;EMJ Urology;2024-05-21

2. The percentage of positive biopsy cores in predicting biochemical recurrence and adverse pathology in prostate cancer patients after radical prostatectomy: a systematic review and meta-analysis;Bali Medical Journal;2023-01-20

3. Improvements in Prostate Cancer Management: Focus on Imaging and Treatment;EMJ Urology;2022-08-15

4. Vroegdetectie van prostaatkanker bij de geïnformeerde gezonde man;Tijdschrift voor Geneeskunde;2022-05-02

5. Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer;Cancer Causes & Control;2021-07-27